To gain insights into the importance of NF‐κB signaling in endothelial dysfunction triggered by PRMT1 inhibition, we examined the nuclear localization of p65/NF‐κB in response to furamidine and TNF‐α treatment by immunostaining and nuclear fractionation (Figure8A,B). The gene discussed is TNF; the disease is endothelial dysfunction.